NCT05527080

Brief Summary

PILKE study uses wearables for assessing motor development in infants in order to define functional growth trajectories in the normal infants and infants at risk of neurological compromise. In addition, PILKE studies correlation of early motor development to later neurocognitive development.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
20mo left

Started Oct 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Oct 2021Dec 2027

Study Start

First participant enrolled

October 1, 2021

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

August 23, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 2, 2022

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2027

Last Updated

April 3, 2025

Status Verified

March 1, 2025

Enrollment Period

5.2 years

First QC Date

August 23, 2022

Last Update Submit

March 30, 2025

Conditions

Keywords

wearablemedical wearablehuman activity recognitiongrowth chartneurodevelopment

Outcome Measures

Primary Outcomes (2)

  • neurocognitive development

    The total score of the neuropsychological examination Bayley scales III will be used

    24 months

  • neurological development

    Binary information (normal vs abnormal) is taken from the postnatal follow-up clinic inspection that is done according to the national standards (www.thl.fi)

    12 months

Study Arms (3)

typically developing infants

recruitment at 5-8mos of age; infants are considered typically developing if they are born at term age with no neurologically significant medical history, and they are not medically followed up for a suspicion of such. The benchmark for this is taken from the nationally harmonized pre/postnatal screening practise.

neurodevelopmental concern

recruitment at 5-8mos of age; infants are recruited from the outpatient clinic in the New Children's hospital (NCH). They have either a known perinatal risk factor (e.g.stroke, HIE, meningitis), or they are referred to pediatric neurologists at NCH due to a suspected delay or deviance in neurodevelopment.

Other: physiotherapy

hip dysplasia concern

recruitment at 2-6 weeks of age after perinatal clinical suspicion of hip dysplacia. These infants may be left out of follow-up (mild), or treated by orthopedic clinic with a soft brace (moderate) or a stronger cast (sever)

Device: brace

Interventions

Some infants will receive physiotherapy as a part of their clinically indicated care.

neurodevelopmental concern
braceDEVICE

Some infants in the hip dysplasia group will receive brace and/or cast as a part of their clinically indicated care

Also known as: cast
hip dysplasia concern

Eligibility Criteria

Age5 Months - 26 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Infants at 5-8mos of age. Upper age limit may be extended until the infant learns to stand up. Groups have either no medical history (#1) or a suspicion or risk of neurodevelopmental delay/deviance (#2)

You may qualify if:

  • age at enrollment 5-8mos
  • typically developing

You may not qualify if:

  • all neurologically significant medical histories during pregnancy, at birth or postnatally
  • suspicion of developmental delay
  • suspicion or diagnosis of syndromes with neuromotor symptoms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BABA, Clinical Trial Unit, New Children's Hospital

Helsinki, Finland

RECRUITING

Related Publications (2)

  • Yamada T, Nakamura K, Horie K, Yamashita Y, Iwaku M. [Extent of odontoblast process in normal and carious dentin]. Kokubyo Gakkai Zasshi. 1982 Jun;49(2):325-32. No abstract available. Japanese.

    PMID: 6957504BACKGROUND
  • Airaksinen M, Gallen A, Kivi A, Vijayakrishnan P, Hayrinen T, Ilen E, Rasanen O, Haataja LM, Vanhatalo S. Intelligent wearable allows out-of-the-lab tracking of developing motor abilities in infants. Commun Med (Lond). 2022 Jun 15;2:69. doi: 10.1038/s43856-022-00131-6. eCollection 2022.

    PMID: 35721830BACKGROUND

Related Links

MeSH Terms

Conditions

Neurodevelopmental DisordersLearning Disabilities

Interventions

Physical Therapy ModalitiesBracesCasts, Surgical

Condition Hierarchy (Ancestors)

Mental DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitationOrthotic DevicesOrthopedic EquipmentSurgical EquipmentEquipment and SuppliesExternal FixatorsOrthopedic Fixation DevicesSurgical Fixation Devices

Study Officials

  • Sampsa K Vanhatalo, prof

    University of Helsinki

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sampsa Vanhatalo, prof

CONTACT

Leena Haataja, prof

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor in clinical neurophysiology

Study Record Dates

First Submitted

August 23, 2022

First Posted

September 2, 2022

Study Start

October 1, 2021

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2027

Last Updated

April 3, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations